In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

A recent study published in the Journal of the American Dental Association found that Tirzepatide presented a novel strategy ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online March 14 in JAMA Health ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

A FAT jab user has revealed that after stopping the injections for eight weeks, she has now realised she is a “Mounjaro lifer ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 ...